Neuroprotective Effect of Garcinia Mangostana on Streptozotocin Induced Sporadic Type Alzheimer’s Disease in Mice

Avinash P, Arun Reddy R, Nazia Begum, Dr. Vasudha Bakshi



Objectives: The main objective of the study is to determine the neuroprotective potential of ethonolic extract of Garcinia mangostana (EEGM) in mouse against Intracerebroventricular- Streptozotocin (ICV –STZ) induced sporadic type Alzheimer‟s disease. Methods: Neurotoxicity was induced by ICV injection of STZ (0.5 mg/kg/b.w) as a first dose then the second dose after the 48 hours and the animals were pre-treated with ethanolic extract of Garcinia mangostana for 28 days. To assess the behavioral parameters learning and memory, open field and Y-maze were employed. Acetylcholinesterase, antioxidant enzymes (superoxide dismutase, glutathione peroxidise, reduced glutathione and catalase) were estimated in brain tissue. Results: Pre-treatment with EEGM (200 and 400 mg/kg/b.w) exhibited a dose dependent reduction of AChE levels and increased habituation memory and percentage alteration which are indicative of the enhanced cognitive function. The extract showed significant increase in the antioxidant parameter. Conclusion: The study results suggested that the neuroprotective potentiality of EEGM against ICV STZ induced neurotoxicity. The extract of EEGM proved to have a potential therapeutic action in preventing or decreasing the progression of sporadic Alzheimer‟s disease due to aging and oxidative stress.


Neuroprotective Effect; Garcinia Mangostana; Streptozotocin; Induced; Sporadic Type; Alzheimer’s Disease;

Full Text:



Agrawal R, Tyagi E, Shukla R, Nath C (2009). A Study of brain insulin receptors, AChEactivity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology. 56, 779–787.

Awasthi H, Tota S, Hanif K, Nath C, Shukla (2010). Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci.86, 87–94.

Beutler E (1963). Reduced glutathione estimation. J Lab Clin Med .61,82.

Blokland A and Jolles J (1993). Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol. Biochem. Behav. 44, 491–494.

Chen LG, Yang LL, Wang CC (2008). Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 46, 688–693.

Cizza G, Calogero AE, Brady LS, Bagdy G, Bergamini E, Blackman MR,Chrousos GP, Gold PW (1994). Male Fischer 344=N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology. 134, 1611–1620.

De la Monte SM, Wands JR (2005). Review of insulin and insulin like growth factor expression,signaling and malfunction in the central nervous system: relevance to alzheimers disease. J.Alzheimer Dis. 7, 45-61.

De la Torre JC (2008). Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis. 5, 126-132.

Droge W, Kinscherf R (2008). Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid. Redox Signal. 10, 661–678.

Ellman GL, Courtney KD, Valentino A, Featherstone RM (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7, 88–95.

Feillet-Coudray C, Rock E, Coudray C, Grzelkowska K, Azais- Braesco V, Dardevet D, Mazur A (1999). Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chim. Acta. 284, 31– 43.

Goth L (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin.Chim.Acta. 196, 143–152.

Govindachari TRKP, Muthukumaraswamy N (1971). Xanthones of Garcinia Mangostana Linn. Tetrahedron 27, 3919–3926..

Halliwell B (2001). Role of free radicals in the neurodegenerativediseases: therapeutic implications for antioxidant treatment. Drugs Aging. 18, 685–716.

Hellweg R, Nitsch R, Hock C, Jaksch M, Hoyer S (1992). Nerve growth factor and cholineacetyltransferase activity levels in the rat brain following experimentalimpairment of cerebral glucose and energy metabolism. J Neurosci Res.31, 479–86.

Hoyer S, Nitsch R, Oesterreich K (1991). Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J. Neural Transm. Park. Dis. Dement. Sect. 31, 1–14.

Jiang DJ, Hu GY, Jiang JL, Xiang HL, Deng HW, Li YJ (2003). Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorganic & Medicinal Chemistry. 11, 5171–5177.

Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F, (2009a). Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's disease. Brain Res.281, 117-12720, 1-10.

Ishrat T, Hoda MN, Khan M.B, Yousuf S, Ahmad M, Khan MM, Ahmad A, Islam F (2009b). Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur. Neuropsychopharmacol. 1-12.

Kondo M, Zhang L, Ji H, Kou Y, Ou B (2009). Bioavailability and antioxidant effects of a xanthone-rich Mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem. 57:8788–8792.

Lannert H, Hoyer S, (1998). Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci.112, 1199–208.

Laursen SE, Belknap JK (1986). Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods.16, 355–357.

Lawrence RA, Burk RF (1976). Glutathione peroxidase activity in selenium- deficient ratliver.Biochem.Biophys.Res.Commun.71, 952–958.

Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006). Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease. J Alzheimers Dis.9,13–33.

Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, Baudry M (2001). Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/ catalase mimetics. Proc. Natl Acad. Sci. USA 100.

Maria RR, Ivan I, Maria CBR, Jose AZ, Daniela B, Amelia TH (2005). Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol. Res.52, 457–462.

Marklund S, Marklund G (1974). ‘Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase’, European Journal of Biochemistry. 47, 469–474.

Marquez-Valadez B, Lugo-Huitron R, Valdivia-Cerda V, Miranda-Ramirez LR, Perez-De La Cruz V, Gonzalez-Cuahutencos O, Rivero-Cruz I, Mata R, Santamaria A, Pedraza-Chaverri J (2009). The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue. Nutr Neurosci. 12:35–42.

Matsumoto K, Akao Y, Kobayashi E, Ohguchi K, Ito T, Iinuma M, Nozawa Y (2003). Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J. Nat. Prod. 66, 1124–1127.

Michon A (2009). The concept of mild cognitive impairment: relevance and limits in Clinical practice. Front Neurol Neurosci. 24, 12-29.

Pedraza-Chaverri j, Cardenas-Rodriguez, N., Orozco-Ibarra, M., Perez-Rojas., J.M., 2008. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol. 46, 3227-3239.

Peres V, Nagem TJ, Faustino de Oliveira F (2000). Tetraoxygenated naturally occurring xantones. Phytochemistry 55, 683–710.

Placanica ZL, Li YM (2009). Gender- and Age-Dependent c-Secretase activity in mouse brain and its implication in Sporadic Alzheimer Disease. Plos One. (4)4, e5088.

Plaschke K Hoyer S (1993). Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int. J. Dev Neurosci. 11, 477-483.

Prickaerts J, Fahrig T, Blokland A (1999). Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an ICV. injection of streptozotocin: a correlation analysis. Behav. Brain. Res. 102, 73–88.

Reddy DS (1997). Assessment of notropic and amnestic activity of centrally acting agents. Indian J.Pharmacol. , 208–221.

Reed TT, Pierce WM, Maresbery WR, Butterfield DA (2009). Proteomic Identification of HNE bound proteins in early Alzheimer disease: Insight into the role of lipid peroxidationin the progression of AD. Brain Research. 1274, 66-76.

Salkovic-Petrisic M (2008). Amyloid cascade hypothesis: is it true for sporadic Alzheimer’s disease. Periodicum Biologrum. 110, 17-25.

Sharma M, Gupta YK (2000). Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sciences. 68/9, 1021–9.

Shoham S, Bejar C, Kovalev E, Weinstock M (2003). Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol. 184, 1043–1052.

Sultanbawa MUS (1980). Xanthonoids of tropical plants. Tetrahedron 36, 1465– 1506.

Tota S, Awasthi H, Kamat PK, Nath C, Hanif K (2010). Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impferairment of memory in mice. Behav Brain Res. 209, 73–79.

Tangponga J, Miriyalab S, Noelb T, Sinthupibulyakitb C, Jungsuwadeeb P (2011). Doxorubicin-Induced Central Nervous System Toxicity And Protection By Xanthone Derivative Of Garcinia Mangostana. Neuroscience.175, 292-299.

Wang Y, Xia Z, Xu JR, Wang YX, Hou LN, Qiu Y, Chen HZ (2012). α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation. Neuropharmacology, 62 , 871–881.

Weecharangsan W, Opanasopit P, Sukma M, Ngawhirunpat T, Sotanaphun, U, Siripong P (2006). Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.). Med. Princ. Pract. 15, 281–287.

Weinstock M, Shoham S (2004). Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J. Neural Transm. 111, 347–366.

Wickens AP (2001). Ageing and the free radical theory. Respir. Physiol. 28, 379–391.

Zawia NH, Lahiri DK, Cardozo-Pelaez F (2009). Epigenetics, oxidative stress, and Alzheimer’s disease. Free Radic. Biol Med. 46, 1241-1249.



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License
International Journal of Applied Pharmaceutical Sciences and Research by Sierra Journals is licensed under a
Based on a work at